MHLW Panel OKs Onoact for Pediatric Tachyarrhythmia and More Drugs

A key health ministry advisory committee on August 4 gave the blessing to a pediatric indication of Ono Pharmaceutical’s tachyarrhythmia drug Onoact (landiolol) and other label expansions for approval. The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on...read more